Ligand Pharmaceuticals Incorporated

The current price of LGND is $316.13 — it has increased by 0.83% since the previous close. Data as of Nov 4, 2026.

LGND is down 0.97% over the past week, up 4.35% over the past month and up 66.87% over the past year. The price is above its 200-day moving average of $253.81.

Of the 11 analysts covering Ligand Pharmaceuticals Incorporated, 3 rate it a strong buy and 8 rate it a buy. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.

Ligand Pharmaceuticals Incorporated has a market capitalization of $6.3B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

In its most recent quarterly report, Ligand Pharmaceuticals Incorporated posted earnings of $2.67 per share against an estimate of $2.33, beating expectations by 14.59%. Upcoming reports are listed in the earnings calendar.

Ligand Pharmaceuticals Incorporated reported revenue of $78.75M in its most recent quarter, which has decreased by 31.80% compared with the same quarter a year earlier. Analysts had expected $77M.

Ligand Pharmaceuticals Incorporated has not paid any dividends over the past year.

Companies most comparable to Ligand Pharmaceuticals Incorporated include AbbVie Inc., Amgen Inc., Pfizer Inc., Bristol-Myers Squibb Company and Genmab A/S.

In the latest trading session LGND moved between $310.24 and $319.15, a range of 2.82% of its current price.

Over the past 52 weeks LGND has traded between $175.89 and $326.63. The current price is 3.21% below its 52-week high.